544529 (6)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies trading members that Aptus Pharma Limited has fixed a record date of May 12, 2026 for a bonus issue of 3 equity shares for … | |||||||||||||||
BSE notifies trading members that Aptus Pharma Limited has fixed a record date of May 12, 2026 for a bonus issue of 3 equity shares for every 2 equity shares held, with market lot revised from 2000 to 5000.
| |||||||||||||||
BSE revises price bands for 28 equity scrips effective April 27, 2026. Most scrips are moved to a 5% band, while select scrips are revised … | |||||||||||||||
BSE revises price bands for 28 equity scrips effective April 27, 2026. Most scrips are moved to a 5% band, while select scrips are revised to 1%, 2%, 10%, or 20% bands.
| |||||||||||||||
BSE revises price bands for 40 listed scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment securities. | |||||||||||||||
BSE revises price bands for 40 listed scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment securities.
| |||||||||||||||
BSE revises price bands for 40 scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment stocks. | |||||||||||||||
BSE revises price bands for 40 scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment stocks.
| |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective March 09, 2026, including new additions, stage … | |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective March 09, 2026, including new additions, stage movements, and securities exiting the framework.
| |||||||||||||||
BSE revises price bands for 8 securities including Aptus Pharma, Colinz Laboratories, Gokak Textiles, and others, effective January 30, … | |||||||||||||||
BSE revises price bands for 8 securities including Aptus Pharma, Colinz Laboratories, Gokak Textiles, and others, effective January 30, 2026.
| |||||||||||||||